US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ホーム
投資
株式
イギリス
LSE
Thalia Therapeutics Plc (THAT) 銘柄情報

Thalia Therapeutics Plc (THAT)

0.575

0.00

(0.00%)

終了 6月18日 12:30AM

Thalia Therapeutics Plc (THAT) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.575

( - )

買値

0.55

売値

0.60

出来高

171,495

0.575 日の範囲 0.575

0.425 52 週間の範囲 0.90

時価総額

前日終値

0.575

始値

0.575

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

1,272,376p

発行済株式数

832,280,349

配当利回り

PER

-2.5

1 株当たり利益 (EPS)

-0

歳入

7.07k

純利益

-1.1M

Thalia Therapeutics Plc, a specialist pharmaceutical company, develops nanoparticle silica delivery systems to enhance the cellular delivery and potency of cancer treatments and vaccines in the United Kingdom. It develops Nuvec, a silica nanoparticle delivery system, which has an irregular surface s... Thalia Therapeutics Plc, a specialist pharmaceutical company, develops nanoparticle silica delivery systems to enhance the cellular delivery and potency of cancer treatments and vaccines in the United Kingdom. It develops Nuvec, a silica nanoparticle delivery system, which has an irregular surface structure that traps and protects siRNA/RNA/DNA; and Liptide, a platform to deliver a proprietary siRNA sequence to silence a fibrotic gene. The company also engages in the development of N4 101, an orally delivered inflammation inhibitor which is in the pre-clinical development for treatment of inflammatory bowel disease; and ECP105 for the prevention of ocular scarring. Thalia Therapeutics Plc was formerly known as N4 Pharma Plc and changed its name to Thalia Therapeutics Plc in March 2026. Thalia Therapeutics Plc was incorporated in 1979 and is based in London, the United Kingdom. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.thaliatx.com

本社

London, United Kingdom

設立

1979

Thalia Therapeutics Plc is listed in the sector of the ロンドン証券取引所 with ticker THAT. The last closing price for Thalia Therapeutics was 0.58p. Over the last year, Thalia Therapeutics shares have traded in a share price range of 0.425p to 0.90p.

Thalia Therapeutics currently has 832,280,349 shares in issue. The market capitalisation of Thalia Therapeutics is £4.79 million. Thalia Therapeutics has a price to earnings ratio (PE ratio) of -2.50.

Thalia Therapeutics PLC Change of Registered Address

Thalia Therapeutics PLC 20 April 2026 20 April 2026 Thalia Therapeutics plc ("Thalia" or the "Company") Change of Registered...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.575	0.575	0.575	266236	0.575	DE
4	-0.1	-14.8148148148	0.675	0.752	0.575	629427	0.62784223	DE
12	0.125	27.7777777778	0.45	0.9	0.425	1287290	0.62138279	DE
26	0.1	21.0526315789	0.475	0.9	0.425	1181252	0.61884262	DE
52	0.1	21.0526315789	0.475	0.9	0.425	1181252	0.61884262	DE
156	0.1	21.0526315789	0.475	0.9	0.425	1181252	0.61884262	DE
260	0.1	21.0526315789	0.475	0.9	0.425	1181252	0.61884262	DE

THAT - Frequently Asked Questions (FAQ)

What is the current Thalia Therapeutics Plc share price?

The current share price of Thalia Therapeutics Plc is 0.575p

How many Thalia Therapeutics Plc shares are in issue?

Thalia Therapeutics Plc has 832,280,349 shares in issue

What is the market cap of Thalia Therapeutics Plc?

The market capitalisation of Thalia Therapeutics Plc is GBP 4.79M

What is the 1 year trading range for Thalia Therapeutics Plc share price?

Thalia Therapeutics Plc has traded in the range of 0.425p to 0.90p during the past year

What is the PE ratio of Thalia Therapeutics Plc?

The price to earnings ratio of Thalia Therapeutics Plc is -2.5

What is the cash to sales ratio of Thalia Therapeutics Plc?

The cash to sales ratio of Thalia Therapeutics Plc is 677.27

What is the registered address of Thalia Therapeutics Plc?

The registered address for Thalia Therapeutics Plc is 2 Portman Street, London, Greater London, W1H 6DU

What is the Thalia Therapeutics Plc website address?

The website address for Thalia Therapeutics Plc is www.thaliatx.com

DA88

My crystal ball says HOLD.. this investment will be worth a fortune and disregard the people who suggest theyre smarter than everyone else as they point out the inherent volatility of a pre revenue speculative stock as evidence of their brillance.

jammy32

jammy32 3分前

I think we need to address the fact that the stock has dropped from 82 cents to 34 cents in less than a year. How does the CEO stay in his job with this type of performance

dexprs

Sold Covered Calls in FIVE and NUE above the purchase price and for 6/18 expiration.

Lewrock

Lewrock 3分前

X, I find it interesting that this SEC filing occurred 43 days after Lightwave engaged the law firm Michael Best to consult on patent valuations and licensing negotiations. How many sit down deep dive meetings do you think took place during those 43 days? The framework is now in place to accommodate

Jake731

Jake731 3分前

Why don’t you call them and ask them?

art2426

art2426 4分前

Why? Does he have more weight than this self appointed family CEO? He has made 'hype' proclamations also that have never come true.

ORCA

NOT TO MENTION HE CAN NOT EVEN GO CURRENT ON OTC.LIMITED INFO POS.
https://www.otcmarkets.com/stock/AMMX/news
Limited Information Icon
Pink Limited Market

John Doe 2024

John Doe 2024 4分前

Saving Grace

Saving Grace 4分前

Falling Fast, now that traders did their DD about this pump job with a Fake news release. LoL
https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Fxobee.com%2Fwp-content%2Fuploads%2F2024%2F10%2FArticle-Cover-2.png&f=1&nofb=1&ipt=5ffdf429675bb4dce17c571b436aaf48b398327fa17b3407a610c2c89

nyt

Yes. And I have held them for approx 10 yrs

capgain

capgain 5分前

M. Fitzpatrick, Schauffele, Rahm, Fleetwood, and Reed. 276

vlispxpert

vlispxpert 5分前

Food sector got hammered today, making account look fugly via "value" across the food calls...but I ignore & buy buy buy more calls...dip too much too far today ;)

ORCA

ALSO Q2 IS NOT GOING TO BE GOOD IMO.TWO MONTHS NOW AND NO CONTRACTS.VERY BAD NEWS.Q2 IS ALMOST OVER.AND NO CONTRACT FOR THE LAST 6 WEEKS.

Lime Time

Lime Time 6分前

280,000 .0004 bid
7,592,166 .0005 ask

Hope to get filings soon

Curios George

Curios George 6分前

kegstackz

kegstackz 6分前

yawn. disinterested but just here for roll call.
red or green? no matter
volumes? insignificant
7 figga posish, 0 shares sold
once mo unto da breach deer frenz
sincerest regards,
-willy ackman jr 06/17

Whalatane

Whalatane 6分前

Re MGT silence . They already have one class action suit to deal with ...tomorrow in fact ...they will be very careful in what they say ...or just simple say nothing at all
What Companies CANNOT Do

Make pre-approval claims:
State or imply that the drug is guaranteed to

gitreal

gitreal 7分前

All lies. It would be so easy for AABB to certify the existence of all that "bullion"....but they don't. Can you imagine how this would explode if they would just certify the bullion, or do a complete audit!!??

And you are helping spread the lies. Way to go!!!

waterchaser

waterchaser 7分前

Total PSRU promo abandonment!
Crickets… as it should be.
It’s a good day.

MrGoldTooth

MrGoldTooth 7分前

I'm kind of confused on the markets reaction to the Fed...What was the market expecting...a rate cut? Surely with oil dropping, the market will continue to benefit and inflation drop. It's a total over reaction as far as I'm concerned.

Str8t-talk

Str8t-talk 7分前

Don't you still own shares?

Curios George

Curios George 7分前

Bid has increased by 100MM

Biotrader23

Biotrader23 8分前

spoke again with IR firm Terrie and the SPAC queen hired.. Alex the real estate dude has zero clue about Anavex pipeline or healthcare sector in general.. "what is EMA??"😝

what he did say that I shouldn't worry coz Anavex has so much cash and a very experienced board specializ

Thalia Therapeutics

Agf Enhanced Us Equity I...

Builders Firstsour Dl 01

Franklin Global

Exchange Traded Commodity

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。